| Homeobox B9 promotes the invasion and metastasis of hepatocellular carcinoma cells via the EZH2-MIR203A-SNAI2 axis. | Homeobox B9 promotes the invasion and metastasis of hepatocellular carcinoma cells via the EZH2-MIR203A-SNAI2 axis.
Zhang D, Qiu Y, Zhang W, Du D, Liu Y, Liu L, Li J, Chen Z, Yu X, Ye M, Wang W, Li Z, Shao J., Free PMC Article | 10/19/2024 |
| EZH2 specifically regulates ISL1 during embryonic urinary tract formation. | EZH2 specifically regulates ISL1 during embryonic urinary tract formation.
Mingardo E, Kalanithy JC, Dworschak G, Ishorst N, Yilmaz Ö, Lindenberg T, Hollstein R, Felger T, Angrand PO, Reutter H, Odermatt B., Free PMC Article | 10/9/2024 |
| EZH2 represses mesenchymal genes and upholds the epithelial state of breast carcinoma cells. | EZH2 represses mesenchymal genes and upholds the epithelial state of breast carcinoma cells.
Gallardo A, López-Onieva L, Belmonte-Reche E, Fernández-Rengel I, Serrano-Prados A, Molina A, Sánchez-Pozo A, Landeira D., Free PMC Article | 10/3/2024 |
| LncRNA CARMN facilitates odontogenic differentiation of dental pulp cells by impairing EZH2. | LncRNA CARMN facilitates odontogenic differentiation of dental pulp cells by impairing EZH2.
Li H, Huo S, He X, Guo D, Liu Y, Zheng L, Zhou X. | 09/24/2024 |
| MTF2 facilitates the advancement of osteosarcoma through mediating EZH2/SFRP1/Wnt signaling. | MTF2 facilitates the advancement of osteosarcoma through mediating EZH2/SFRP1/Wnt signaling.
Hu X, Liu Y, Shen H, Zhang T, Liang T., Free PMC Article | 09/17/2024 |
| TXNIP mediated by EZH2 regulated osteogenic differentiation in hBmscs and MC3T3-E1 cells through the modulation of oxidative stress and PI3K/AKT/Nrf2 pathway. | TXNIP mediated by EZH2 regulated osteogenic differentiation in hBmscs and MC3T3-E1 cells through the modulation of oxidative stress and PI3K/AKT/Nrf2 pathway.
Zhou W, Zhu C, Zhou F. | 09/3/2024 |
| A novel EZH2/NXPH4/CDKN2A axis is involved in regulating the proliferation and migration of non-small cell lung cancer cells. | A novel EZH2/NXPH4/CDKN2A axis is involved in regulating the proliferation and migration of non-small cell lung cancer cells.
Yang Z, Wei B, Qiao A, Yang P, Chen W, Zhen D, Qiu X. | 08/30/2024 |
| LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing. | LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.
Lin YH, Wu MH, Liu YC, Lyu PC, Yeh CT, Lin KH. | 08/28/2024 |
| PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration. | PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration.
Wang J, Shen S, You J, Wang Z, Li Y, Chen Y, Tuo Y, Chen D, Yu H, Zhang J, Wang F, Pang X, Xiao Z, Lan Q, Wang Y., Free PMC Article | 08/23/2024 |
| TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway. | TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway.
Cai L, Liu Y, Li Y, Liu B, Cao Y, Yang W, Wang B, Sun T. | 08/23/2024 |
| NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression. | NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression.
Yang Y, Fan H, Liu H, Lou X, Xiao N, Zhang C, Chen H, Chen S, Gu H, Liu H, Wan J., Free PMC Article | 08/14/2024 |
| YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation. | YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation.
Wang S, Xu L, Wang D, Zhao S, Li K, Ma F, Yao Q, Zhang Y, Wu Z, Shao Y, Song S, Yan W. | 08/1/2024 |
| UBR7 in concert with EZH2 inhibits the TGF-beta signaling leading to extracellular matrix remodeling. | UBR7 in concert with EZH2 inhibits the TGF-β signaling leading to extracellular matrix remodeling.
Adhikari S, Singh V, Nandi S, Ghosal M, Raj NS, Khanna J, Bhattacharya A, Kabiraj A, Mondal A, Vasudevan M, Senapati D, Roy H, Sengupta K, Notani D, Das C. | 07/31/2024 |
| Enzyme-independent role of EZH2 in regulating cell cycle progression via the SKP2-KIP/CIP pathway. | Enzyme-independent role of EZH2 in regulating cell cycle progression via the SKP2-KIP/CIP pathway.
Colon T, Kou Z, Choi BH, Tran F, Zheng E, Dai W., Free PMC Article | 06/21/2024 |
| Identification and functional analysis of the hub Ferroptosis-Related gene EZH2 in diabetic kidney disease. | Identification and functional analysis of the hub Ferroptosis-Related gene EZH2 in diabetic kidney disease.
Wang H, Wang J, Ran Q, Leng Y, Liu T, Xiong Z, Zou D, Yang W. | 06/17/2024 |
| RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer. | RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
Wang R, Tan W. | 06/14/2024 |
| LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1. | LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1.
Cai Y, Liu Y, Sun Y, Ren Y. | 05/31/2024 |
| Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells. | Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.
Jacksi M, Schad E, Tantos A., Free PMC Article | 05/20/2024 |
| MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2. | MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2.
Yu H, Xu X, Zhu L, Chen S, He J., Free PMC Article | 05/20/2024 |
| TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present. | TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present.
Kim DH, Siddiqui S, Jain P, Wang M, Thakral B, Li S, Miranda R, Vega F, Medeiros LJ, Ok CY. | 05/9/2024 |
| EZH2 Promotes Multiple Myeloma Progression via STAT3 Pathway Activation. | EZH2 Promotes Multiple Myeloma Progression via STAT3 Pathway Activation.
Wang Y, Tian J, Huang D, Gao Y, Lin H, Liu L, Wang A. | 04/30/2024 |
| Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2. | Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2.
Sun H, Zhu R, Guo X, Zhao P, Zhang R, Zhao Z, Zhou H. | 04/17/2024 |
| EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action. | EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action.
Mohebbi H, Esbati R, Hamid RA, Akhavanfar R, Radi UK, Siri G, Yazdani O. | 04/3/2024 |
| MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2. | MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2.
Sinha A, Ghosh A, Ghosh A, Mathai S, Bhaumik J, Mukhopadhyay A, Maitra A, Biswas NK, Sengupta S., Free PMC Article | 03/28/2024 |
| EZH2-mediated development of therapeutic resistance in cancer. | EZH2-mediated development of therapeutic resistance in cancer.
Kaur P, Shankar E, Gupta S. | 03/19/2024 |